Q
QuantAbundanciaAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

27,917 signal articles · 57 in last 24h · 135,654 total before filter · latest 1h ago
57last 24h
1094last 7d
178● bullish (7d)
141● bearish (7d)
209publishers
AllMacro301Earnings359M&A77Regulatory25Product11Analyst14
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Merck (MRK) Surges on a Melanoma Win. Can Intismeran Extend Keytruda’s Growth Runway?
Insider Monkey11d agobullish
Merck (MRK) Surges on a Melanoma Win. Can Intismeran Extend Keytruda’s Growth Runway?

Merck & Co., Inc. (NYSE:MRK) jumped 12.6% to a record $152.20 on August 19 after a pivotal melanoma trial validated intismeran autogene, the individualized mRNA cancer therapy developed with Moderna. In the 1,137-patient Phase 3 INTerpath-001 study, intismeran plus Keytruda produced statistically significant and clinically meaningful improvements in recurrence-free survival and distant-metastasis-free survival compared with […]

3 Reasons NWBI is Risky and 1 Stock to Buy Instead
StockStory11d agobullish
3 Reasons NWBI is Risky and 1 Stock to Buy Instead

Northwest Bancshares’s 19% return over the past six months has outpaced the S&P 500 by 8.5%, and its stock price has climbed to $15.38 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

Here's Why AXT (AXTI) Is a Great 'Buy the Bottom' Stock Now
Zacks11d agobullish
Here's Why AXT (AXTI) Is a Great 'Buy the Bottom' Stock Now

AXT (AXTI) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

3 Reasons to Avoid AMKR and 1 Stock to Buy Instead
StockStory11d agobullish
3 Reasons to Avoid AMKR and 1 Stock to Buy Instead

Over the past six months, Amkor’s stock price fell to $47.82. Shareholders have lost 6.1% of their capital, which is disappointing considering the S&P 500 has climbed by 10.5%. This may have investors wondering how to approach the situation.

Wall Street Bulls Look Optimistic About Cisco (CSCO): Should You Buy?
Zacks11d agobullish
Wall Street Bulls Look Optimistic About Cisco (CSCO): Should You Buy?

According to the average brokerage recommendation (ABR), one should invest in Cisco (CSCO). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Wall Street Analysts See TJX (TJX) as a Buy: Should You Invest?
Zacks11d agobullish
Wall Street Analysts See TJX (TJX) as a Buy: Should You Invest?

According to the average brokerage recommendation (ABR), one should invest in TJX (TJX). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Is Eaton (ETN) a Buy as Wall Street Analysts Look Optimistic?
Zacks11d agobullish
Is Eaton (ETN) a Buy as Wall Street Analysts Look Optimistic?

The average brokerage recommendation (ABR) for Eaton (ETN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?